nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts from the ASENT 17th Annual Meeting
|
Clarence-Smith, K. |
|
2015 |
12 |
3 |
p. 678-687 |
artikel |
2 |
Abstracts from the ASENT 17th Annual Meeting
|
Clarence-Smith, K. |
|
|
12 |
3 |
p. 678-687 |
artikel |
3 |
Angelman Syndrome
|
Margolis, Seth S. |
|
2015 |
12 |
3 |
p. 641-650 |
artikel |
4 |
Angelman Syndrome
|
Margolis, Seth S. |
|
|
12 |
3 |
p. 641-650 |
artikel |
5 |
Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy
|
Hagen, Eunice |
|
2015 |
12 |
3 |
p. 657-666 |
artikel |
6 |
Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy
|
Hagen, Eunice |
|
|
12 |
3 |
p. 657-666 |
artikel |
7 |
Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder
|
Tilot, Amanda K. |
|
2015 |
12 |
3 |
p. 609-619 |
artikel |
8 |
Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder
|
Tilot, Amanda K. |
|
|
12 |
3 |
p. 609-619 |
artikel |
9 |
Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism
|
Ellegood, Jacob |
|
2015 |
12 |
3 |
p. 521-533 |
artikel |
10 |
Behavioral and Neuroanatomical Phenotypes in Mouse Models of Autism
|
Ellegood, Jacob |
|
|
12 |
3 |
p. 521-533 |
artikel |
11 |
Bridging the Gap in Neurotherapeutic Discovery and Development: The Role of the National Institute of Neurological Disorders and Stroke in Translational Neuroscience
|
Mott, Meghan |
|
2015 |
12 |
3 |
p. 651-654 |
artikel |
12 |
Bridging the Gap in Neurotherapeutic Discovery and Development: The Role of the National Institute of Neurological Disorders and Stroke in Translational Neuroscience
|
Mott, Meghan |
|
|
12 |
3 |
p. 651-654 |
artikel |
13 |
Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms
|
Gamsiz, Ece D. |
|
2015 |
12 |
3 |
p. 553-571 |
artikel |
14 |
Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms
|
Gamsiz, Ece D. |
|
|
12 |
3 |
p. 553-571 |
artikel |
15 |
Inhibition-Based Biomarkers for Autism Spectrum Disorder
|
Levin, April R. |
|
2015 |
12 |
3 |
p. 546-552 |
artikel |
16 |
Inhibition-Based Biomarkers for Autism Spectrum Disorder
|
Levin, April R. |
|
|
12 |
3 |
p. 546-552 |
artikel |
17 |
Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment
|
Meng, Ran |
|
2015 |
12 |
3 |
p. 667-677 |
artikel |
18 |
Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment
|
Meng, Ran |
|
|
12 |
3 |
p. 667-677 |
artikel |
19 |
Ischemic Preconditioning: The Long-Awaited Savior of Neuroprotection. Has It Arrived?
|
Selim, Magdy |
|
2015 |
12 |
3 |
p. 655-656 |
artikel |
20 |
Ischemic Preconditioning: The Long-Awaited Savior of Neuroprotection. Has It Arrived?
|
Selim, Magdy |
|
|
12 |
3 |
p. 655-656 |
artikel |
21 |
Phelan–McDermid Syndrome and SHANK3: Implications for Treatment
|
Costales, Jesse L. |
|
2015 |
12 |
3 |
p. 620-630 |
artikel |
22 |
Phelan–McDermid Syndrome and SHANK3: Implications for Treatment
|
Costales, Jesse L. |
|
|
12 |
3 |
p. 620-630 |
artikel |
23 |
Rett Syndrome: Reaching for Clinical Trials
|
Pozzo-Miller, Lucas |
|
2015 |
12 |
3 |
p. 631-640 |
artikel |
24 |
Rett Syndrome: Reaching for Clinical Trials
|
Pozzo-Miller, Lucas |
|
|
12 |
3 |
p. 631-640 |
artikel |
25 |
Therapeutic Advances in Autism and Other Neurodevelopmental Disorders
|
Neul, Jeffrey L. |
|
2015 |
12 |
3 |
p. 519-520 |
artikel |
26 |
Therapeutic Advances in Autism and Other Neurodevelopmental Disorders
|
Neul, Jeffrey L. |
|
|
12 |
3 |
p. 519-520 |
artikel |
27 |
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
|
Gross, Christina |
|
2015 |
12 |
3 |
p. 584-608 |
artikel |
28 |
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
|
Gross, Christina |
|
|
12 |
3 |
p. 584-608 |
artikel |
29 |
The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
|
Acab, Allan |
|
2015 |
12 |
3 |
p. 534-545 |
artikel |
30 |
The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
|
Acab, Allan |
|
|
12 |
3 |
p. 534-545 |
artikel |
31 |
Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism
|
Davis, Peter E. |
|
2015 |
12 |
3 |
p. 572-583 |
artikel |
32 |
Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism
|
Davis, Peter E. |
|
|
12 |
3 |
p. 572-583 |
artikel |